Vol. 12, Special Issue 7 (2023)

Author(s):
Chandan Kumar Panigrahi, Simran Mahapatra and Bijoy Kumar Mishra

Abstract:
A Research trial was conducted during rabi 2023 at CRF,SHUATS (Sam Higginbottom University of Agriculture, Technology and Sciences), Prayagraj, Uttar Pradesh (India) to evaluate the cost benefit ratio by using different insecticidal applications which is Chlorantraniliprole-T1@150ml/ha, Thiomethoxam 12.6 + Lambda cyhalothrin 9.5ZC-T2@200ml/ha, Lambda cyhalothrin 5EC-T3@750ml/ha, Spinosad 45SC-T4 @200ml/ha, Emamectin benzoate 5SG-T5 @200gm/ha, Flubendiamide 49.35SC-T6@ 200ml/ha, Beauveria bassiana 5% WP – T7@2.5kg/ha and untreated control, replicated thrice under RBD. The yields of treatments were significant and the highest yield was seen in Emamectin benzoate 5SG (42.5 q/ha), followed by Lambda cyhalothrin 5EC (40.5 q/ha) and Spinosad 45SC (37.8 q/ha) ranked 3^rd among the seven treatments. The highest CBR (cost benefit ratio) of (1:2.42) was observed in Emamectin benzoate 5SG followed by Lambda cyhalothrin 5EC (1:2.3) and with Spinosad 45SC (1:1.83).